Literature DB >> 17090406

Evidence of vascular damage in dengue disease: demonstration of high levels of soluble cell adhesion molecules and circulating endothelial cells.

José E Cardier1, Betty Rivas, Egidio Romano, Alan L Rothman, Carlos Perez-Perez, Mariangel Ochoa, Ana M Caceres, Marisabel Cardier, Napoleón Guevara, Roberto Giovannetti.   

Abstract

Clinical evidence suggests that vascular damage plays a key role in the pathophysiology of dengue hemorrhagic fever (DHF). In this study, the authors tested this hypothesis by examining the levels of soluble intercellular adhesion molecule and vascular cell adhesion molecule (sICAM-1 and sVCAM-1), and the presence of circulating endothelial cells (CECs), as evidence of vascular damage, in peripheral blood from DHF patients (n=13). A significant increase in plasma levels of sICAM-1 (n=12) and sVCAM-1 (n=13) was detected by enzyme-linked immunosorbent assay (ELISA) in DHF patients, compared with healthy individuals. Increased numbers of CECs, as detected by the expression of endothelial cell markers (ICAM-1, platelet cell adhesion molecule [PCAM]-1, and CD36) with flow cytometry, were observed in DHF patients (n=4), compared to healthy subjects. The high levels of sICAM-1 and sVCAM-1, together with the presence of CECs in DHF patients, provide further evidence of endothelium damage and activation in DHF patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17090406     DOI: 10.1080/10623320600972135

Source DB:  PubMed          Journal:  Endothelium        ISSN: 1026-793X


  23 in total

1.  Dengue virus infection of mast cells triggers endothelial cell activation.

Authors:  Michael G Brown; Laura L Hermann; Andrew C Issekutz; Jean S Marshall; Derek Rowter; Ayham Al-Afif; Robert Anderson
Journal:  J Virol       Date:  2010-11-10       Impact factor: 5.103

2.  Association DENV1 and DENV2 infection with high serum levels of soluble thrombomodulin and VEGF in patients with dengue fever and dengue hemorrhagic fever.

Authors:  Oscar Del Moral-Hernández; Norma E Martínez-Hernández; Manuel A Mosso-Pani; Daniel Hernández-Sotelo; Berenice Illades-Aguiar; Eugenia Flores-Alfaro; Verónica Antonio-Vejar; Marco Antonio Leyva-Vázquez
Journal:  Int J Clin Exp Med       Date:  2014-02-15

3.  Dengue fever as a rare cause of pulmonary embolism.

Authors:  Francesco Poletto; Lorenzo Cerruti; Luca Spiezia
Journal:  J Thromb Thrombolysis       Date:  2020-05       Impact factor: 2.300

4.  Endothelial Dysfunction as a Primary Consequence of SARS-CoV-2 Infection.

Authors:  Genevieve Mezoh; Nigel J Crowther
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Enhancement by tumor necrosis factor alpha of dengue virus-induced endothelial cell production of reactive nitrogen and oxygen species is key to hemorrhage development.

Authors:  Yu-Ting Yen; Hsuen-Chin Chen; Hseun-Chin Chen; Yang-Ding Lin; Chi-Chang Shieh; Betty A Wu-Hsieh
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

Review 6.  Dengue virus pathogenesis: an integrated view.

Authors:  Byron E E Martina; Penelope Koraka; Albert D M E Osterhaus
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

7.  Differential regulation of angiopoietin 1 and angiopoietin 2 during dengue virus infection of human umbilical vein endothelial cells: implications for endothelial hyperpermeability.

Authors:  Siew Pei Ong; Mah Lee Ng; Justin Jang Hann Chu
Journal:  Med Microbiol Immunol       Date:  2013-08-30       Impact factor: 3.402

Review 8.  Cardiovascular manifestations of the emerging dengue pandemic.

Authors:  Sophie Yacoub; Heiman Wertheim; Cameron P Simmons; Gavin Screaton; Bridget Wills
Journal:  Nat Rev Cardiol       Date:  2014-04-08       Impact factor: 32.419

9.  Roles for endothelial cells in dengue virus infection.

Authors:  Nadine A Dalrymple; Erich R Mackow
Journal:  Adv Virol       Date:  2012-08-16

10.  Cytokine expression profile of dengue patients at different phases of illness.

Authors:  Anusyah Rathakrishnan; Seok Mui Wang; Yongli Hu; Asif M Khan; Sasheela Ponnampalavanar; Lucy Chai See Lum; Rishya Manikam; Shamala Devi Sekaran
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.